Survey about do-it-yourself closed loop systems in the treatment of diabetes in Germany.

by Anna Laura Herzog, Jonas Busch, Christoph Wanner, Holger K von Jouanne-Diedrich
Published 2020-01-01

Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time

by Detlef H. Krieter, Simon Kerwagen, Marieke Rüth, Horst-Dieter Lemke, Christoph Wanner
Published 2019-01-01

Rosiglitazone Affects Nitric Oxide Synthases and Improves Renal Outcome in a Rat Model of Severe Ischemia/Reperfusion Injury

by Boris Betz, Reinhard Schneider, Tobias Kress, Martin Alexander Schick, Christoph Wanner, Christoph Sauvant
Published 2012-01-01

Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.

by Nurcan Üçeyler, Nils Schröter, Waldemar Kafke, Daniela Kramer, Christoph Wanner, Frank Weidemann, Claudia Sommer
Published 2016-01-01

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data...

by Hansjörg Rothe, Vincent Brandenburg, Margot Haun, Barbara Kollerits, Florian Kronenberg, Markus Ketteler, Christoph Wanner
Published 2017-01-01

Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients

by Sören Jendrik Grebe, Uwe Malzahn, Julian Donhauser, Dan Liu, Christoph Wanner, Vera Krane, Fabian Hammer
Published 2020-09-01

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME® trial

by Takashi Kadowaki, Masaomi Nangaku, Stefan Hantel, Tomoo Okamura, Maximilian vonEynatten, Christoph Wanner, Audrey Koitka‐Weber
Published 2019-05-01

Transthyretin Predicts Cardiovascular Outcome In Hemodialysis Patients With Diabetes Mellitus Type 2

by Andrea Henze, Katharina Espe, Christoph Wanner, Vera Krane, Jens Raila, Berthold Hocher, Florian J. Schweigert, Christiane Drechsler
Published 2012-06-01

Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.

by Johannes Krämer, Bart Bijnens, Stefan Störk, Christian O Ritter, Dan Liu, Georg Ertl, Christoph Wanner, Frank Weidemann
Published 2015-01-01

Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease.

by Nurcan Uçeyler, György A Homola, Hans Guerrero González, Daniela Kramer, Christoph Wanner, Frank Weidemann, László Solymosi, Claudia Sommer
Published 2014-01-01

Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.

by Andreas Schneider, Markus P Schneider, Detlef H Krieter, Bernd Genser, Hubert Scharnagl, Tatjana Stojakovic, Christoph Wanner, Christiane Drechsler
Published 2015-01-01

COVID-19 and the kidney: A retrospective analysis of 37 critically ill patients using machine learning.

by Anna Laura Herzog, Holger K von Jouanne-Diedrich, Christoph Wanner, Dirk Weismann, Tobias Schlesinger, Patrick Meybohm, Jan Stumpner
Published 2021-01-01

Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME

by Pierpaolo Pellicori, Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis George, Bernard Zinman, Martina Brueckmann, JoAnn Lindenfeld
Published 2020-12-01

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes

by Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J. L. Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl
Published 2021-03-01

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.

by Maria Köping, Wafaa Shehata-Dieler, Mario Cebulla, Kristen Rak, Daniel Oder, Jonas Müntze, Peter Nordbeck, Christoph Wanner, Rudolf Hagen, Sebastian Schraven
Published 2017-01-01

Characterization of vertigo and hearing loss in patients with Fabry disease

by Maria Köping, Wafaa Shehata-Dieler, Dieter Schneider, Mario Cebulla, Daniel Oder, Jonas Müntze, Peter Nordbeck, Christoph Wanner, Rudolf Hagen, Sebastian P. Schraven
Published 2018-08-01

Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

by Martin Wagner, Damien R Ashby, Caroline Kurtz, Ahsan Alam, Mark Busbridge, Ulrike Raff, Josef Zimmermann, Peter U Heuschmann, Christoph Wanner, Lothar Schramm
Published 2015-01-01

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

by João Pedro Ferreira, Subodh Verma, David Fitchett, Anne Pernille Ofstad, Sabine Lauer, Isabella Zwiener, Jyothis George, Christoph Wanner, Bernard Zinman, Silvio E. Inzucchi
Published 2020-11-01

Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.

by Christiane Drechsler, Barbara Kollerits, Andreas Meinitzer, Winfried März, Eberhard Ritz, Paul König, Ulrich Neyer, Stefan Pilz, Christoph Wanner, Florian Kronenberg, MMKD Study Group
Published 2013-01-01

Patient’s and physician’s awareness of kidney disease in coronary heart disease patients – a cross-sectional analysis of the German subset of the EUROASPIRE IV survey

by Martin Wagner, Christoph Wanner, Martin Schich, Kornelia Kotseva, David Wood, Katrin Hartmann, Georg Fette, Viktoria Rücker, Mehmet Oezkur, Stefan Störk, Peter U. Heuschmann
Published 2017-10-01